testosterone

all catalysts(0)

nothing on the calendar yet

News(10)

• A new, separate outbreak of the diarrhea-causing parasite
  A win for peptide proponents, autism advisory committees clash, and more health news from Morning Rounds
  stat · 26d ago
• Expect a clash at today’s FDA peptide panel
  The service members who refused the Covid vaccine, the fastest-growing Ebola outbreak in history, and other health news from Morning Rounds
  stat · 27d ago
• Opinion: Good riddance to bundled ‘global’ maternal care billing
  New maternal billing codes should create a transparent system where both patients and clinicians can thrive, ACOG writes.
  stat · 28d ago
• Opinion: New billing codes likely to raise maternity care costs
  “This change is likely to lead to only modest increases in total medical expenses. However, it coincides with many other factors raising health insurance premiums,” writes Jeff Levin-Scherz.
  stat · 28d ago
• Job dissatisfaction and health care access uncertainty grows in the U.S., new study finds
  What Hawaii's wildfires can teach the nation about health recovery, 4.5 million people disenrolled from SNAP, and more health news
  stat · 28d ago
• Opinion: STAT+: Hospitals’ AI may be drifting. Who’s watching?
  Senior leaders must treat AI governance as their own daily job, not something the technology committee handles quarterly, write Peter Pronovost, Justin Norden, and Kedar Mate.
  stat · 29d ago
• Opinion: STAT+: I’m a cardiologist. I’m not sure the new cholesterol drug enlicitide is a game-changer
  “In truth, I don’t anticipate prescribing patterns changing immediately,” cardiologist Vishal Khetpal writes of the new cholesterol drug Lipfendra.
  stat · 29d ago
• Opinion: Pete Hegseth, ‘The Odyssey,’ and the testosterone myth
  The poet didn’t say “sing to me, Muse, of a man with optimized endocrine panels," writes urologist Elizabeth Dray.
  stat · 29d ago
• A renewed push from the right against abortion pills
  The latest on cyclospora, THC sodas at the grocery store, and more health news from Morning Rounds
  stat · 29d ago
• Opinion: How a controversial rule could hurt the NIH’s ability to manage risk
  The proposed rule could “weaken the NIH’s benign influence over research risks,” writes Doni Bloomfield.
  stat · 1mo ago